All posts tagged in Mounjaro (tirzepatide)

In a significant move aimed at addressing the growing health crisis of obesity and type 2 diabetes, pharmaceutical giant Eli Lilly has launched its highly anticipated drug, Mounjaro (tirzepatide), in